Email this article Erratum in "Results of lenvatinib as first-line targeted therapy for advanced hepatocellular cancer: A retrospective study" (DOI: 10.26442/18151434.2025.2.203293)
- Issue: Vol 27, No 3 (2025)
- Pages: 307-309
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/363033
- DOI: https://doi.org/10.26442/18151434.2025.3.203427
- ID: 363033
Cite item
Full Text
Abstract
In the article «Results of lenvatinib as first-line targeted therapy for advanced hepatocellular cancer: A retrospective study», published in the Journal of Modern Oncology, Vol. 27, No. 2, 2025 (DOI: 10.26442/18151434.2025.2.203293), errors were made: the numerical data from Table 2 in four cells related to two columns (Median PFS and Median OS) were reversed. Data [12.7 (7.6-21.7)] were reversed with [6 (2.3-12.7)]; data [15.1 (3.9-43.8)] were reversed with [10.6 (1.8-16.1)].
Supplementary files
